MedPath

Special Drug Use-results Survey for Long-term Use(Avacopan)

Recruiting
Conditions
Microscopic Polyangiitis (MPA)
Granulomatosis With Polyangiitis (GPA)
Interventions
Registration Number
NCT06758271
Lead Sponsor
Kissei Pharmaceutical Co., Ltd.
Brief Summary

The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.

Detailed Description

The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Avacopan treatmentedAvacopan-
Primary Outcome Measures
NameTimeMethod
Adverse events2 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Research site

🇯🇵

Multiple Locations, Japan

© Copyright 2025. All Rights Reserved by MedPath